Cargando…

P2Y(11)/IL-1 receptor crosstalk controls macrophage inflammation: a novel target for anti-inflammatory strategies?

Although first cloning of the human ATP receptor P2Y(11) was successful 25 years ago, the exact downstream signaling pathways of P2Y(11) receptor, which can couple to G(q) and G(s) proteins, have remained unclear. Especially the lack of rodent models as well as the limited availability of antibodies...

Descripción completa

Detalles Bibliográficos
Autores principales: Klaver, Dominik, Thurnher, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073626/
https://www.ncbi.nlm.nih.gov/pubmed/37016172
http://dx.doi.org/10.1007/s11302-023-09932-3
_version_ 1785019612224552960
author Klaver, Dominik
Thurnher, Martin
author_facet Klaver, Dominik
Thurnher, Martin
author_sort Klaver, Dominik
collection PubMed
description Although first cloning of the human ATP receptor P2Y(11) was successful 25 years ago, the exact downstream signaling pathways of P2Y(11) receptor, which can couple to G(q) and G(s) proteins, have remained unclear. Especially the lack of rodent models as well as the limited availability of antibodies and pharmacological tools have hampered examination of P2Y(11) expression and function. Many meaningful observations related to P2Y(11) have been made in primary immune cells, indicating that P2Y(11) receptors are important regulators of inflammation and cell migration, also by controlling mitochondrial activity. Our recent studies have shown that P2Y(11) is upregulated during macrophage development and activates signaling through IL-1 receptor, which is well known for its ability to direct inflammatory and migratory processes. This review summarizes the results of the first transcriptomic and secretomic analyses of both, ectopic and native P2Y(11) receptors, and discusses how P2Y(11) crosstalk with the IL-1 receptor may govern anti-inflammatory and pro-angiogenic processes in human M2 macrophages.
format Online
Article
Text
id pubmed-10073626
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-100736262023-04-05 P2Y(11)/IL-1 receptor crosstalk controls macrophage inflammation: a novel target for anti-inflammatory strategies? Klaver, Dominik Thurnher, Martin Purinergic Signal Review Article Although first cloning of the human ATP receptor P2Y(11) was successful 25 years ago, the exact downstream signaling pathways of P2Y(11) receptor, which can couple to G(q) and G(s) proteins, have remained unclear. Especially the lack of rodent models as well as the limited availability of antibodies and pharmacological tools have hampered examination of P2Y(11) expression and function. Many meaningful observations related to P2Y(11) have been made in primary immune cells, indicating that P2Y(11) receptors are important regulators of inflammation and cell migration, also by controlling mitochondrial activity. Our recent studies have shown that P2Y(11) is upregulated during macrophage development and activates signaling through IL-1 receptor, which is well known for its ability to direct inflammatory and migratory processes. This review summarizes the results of the first transcriptomic and secretomic analyses of both, ectopic and native P2Y(11) receptors, and discusses how P2Y(11) crosstalk with the IL-1 receptor may govern anti-inflammatory and pro-angiogenic processes in human M2 macrophages. Springer Netherlands 2023-04-05 2023-09 /pmc/articles/PMC10073626/ /pubmed/37016172 http://dx.doi.org/10.1007/s11302-023-09932-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review Article
Klaver, Dominik
Thurnher, Martin
P2Y(11)/IL-1 receptor crosstalk controls macrophage inflammation: a novel target for anti-inflammatory strategies?
title P2Y(11)/IL-1 receptor crosstalk controls macrophage inflammation: a novel target for anti-inflammatory strategies?
title_full P2Y(11)/IL-1 receptor crosstalk controls macrophage inflammation: a novel target for anti-inflammatory strategies?
title_fullStr P2Y(11)/IL-1 receptor crosstalk controls macrophage inflammation: a novel target for anti-inflammatory strategies?
title_full_unstemmed P2Y(11)/IL-1 receptor crosstalk controls macrophage inflammation: a novel target for anti-inflammatory strategies?
title_short P2Y(11)/IL-1 receptor crosstalk controls macrophage inflammation: a novel target for anti-inflammatory strategies?
title_sort p2y(11)/il-1 receptor crosstalk controls macrophage inflammation: a novel target for anti-inflammatory strategies?
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073626/
https://www.ncbi.nlm.nih.gov/pubmed/37016172
http://dx.doi.org/10.1007/s11302-023-09932-3
work_keys_str_mv AT klaverdominik p2y11il1receptorcrosstalkcontrolsmacrophageinflammationanoveltargetforantiinflammatorystrategies
AT thurnhermartin p2y11il1receptorcrosstalkcontrolsmacrophageinflammationanoveltargetforantiinflammatorystrategies